Zhengzhou, China – January 12, 2018, Zhengzhou Granlen PharmaTech, Ltd., a Division of Granlen, Inc. in San Diego, CA, USA, announced the publication of azido-nucleosides by Chinese J. Org. Chem., written in English.

“We are delighted for the publication in the journal’s special issue dedicated to Professor Yangjie Wu on the occasion of his 90th birthday. All kinds of new azido nucleosides were made and can be used for further conjugation or modification in the genomic and related fields”, said Harry An, Ph. D., National “1000 Talents” Awardee, Founder and President, Granlen.

 “Synthesis of 3’-Azido-D- and L-Nucleosides”, Chinese J. Org. Chem., 2018, 38(1), 138-147.

Click here to download the published paper

For more information please visit www.granlen.com or contact

philip.fang, philip.fang@granlen.com; +86-371-85513397

Zhengzhou Granlen PharmaTech Ltd.